| ¿µ¹® | fat | ÇÑ±Û | Áö¹æ |
|---|---|---|---|
| ¼³¸í | 1. Áö¹æÁ¶Á÷À» ³ªÅ¸³»´Â ¸». Áï Èò»öÀ̳ª ³ë¶õ»öÀ» ¶ì´Â ¿¡³ÊÁö¸¦ º¸°üÇÏ´Â ±â´ÉÀ» ÇÏ´Â Á¶Á÷. ¿©·¯ °¡Áö ±â°üµé »çÀÌ¿¡ Á¸ÀçÇÑ´Ù. 2. Áö¹æ»ê°ú ±Û¸®¼¼·ÑÀÌ °áÇÕÇÑ À¯±â ÈÇÕ¹°. »ó¿Â¿¡¼ °íüÀÇ ÇüÅÂÀ̸ç, »ý¹°Ã¼¿¡ ÇÔÀ¯µÇ¾î ÀÖ´Ù. µ¿¹°¿¡¼´Â ÇÇÇÏ-±ÙÀ°-°£ µûÀ§¿¡ ÀúÀåµÇ¸ç, ¿¡³ÊÁö¿øÀÌÁö¸¸ ¸ö¹«°Ô°¡ ´À´Â ¿øÀÎÀÌ µÇ±âµµ ÇÑ´Ù. ±Û¸®¼¼·ÑÀÌ 3°¡ÀÇ ¾ËÄÚ¿ÃÀ̹ǷΠÁö¹æ»êÀº ¼Â±îÁö °áÇÕÇÒ ¼ö Àִµ¥, Áö¹æ»êÀÌ Çϳª °áÇÕÇÑ °ÍÀ» ¸ð³ë¾Æ½Ç±Û¸®¼¼·Ñ(monoacylglycerol) µÑÀÌ °áÇÕÇÑ °ÍÀ» µð¾Æ½Ç±Û¸®¼¼·Ñ(diacylglycerol) ¼ÂÀÌ °áÇÕÇÑ °ÍÀ» Æ®¸®¾Æ½Ç±Û¸®¼¼·Ñ(triacylglycerol) À̶ó°í ÇÑ´Ù. »ýü³»ÀÇ ¸ð³ë¾Æ½Ç±Û¸®¼¼·Ñ ¹× µð¾Æ½Ç±Û¸®¼¼·ÑÀº ±ØÈ÷ ÀûÀº ¾çÀÌÁö¸¸, ÁöÁú´ë»ç¿¡ Áß¿äÇÑ ÀÛ¿ëÀ» ÇÑ´Ù. Æ®¸®¾Æ½Ç±Û¸®¼¼·ÑÀº ±Û¸®ÄÚ°Õ°ú ÇÔ²² ÀúÀå¿¡³ÊÁö·Î µÇ¾î ÀÖ´Ù. |
||
| ¿µ¹® | saturated fat | ÇÑ±Û | Æ÷ÈÁö¹æ |
|---|---|---|---|
| ¼³¸í | ź¼Ò °áÇÕÀÌ ¸ðµÎ ´ÜÀÏ °áÇÕÀ¸·Î ±¸¼ºµÈ Áö¹æ»êÀ¸·Î ÀÌ·ç¾îÁø Áö¹æÀ» ¸»ÇÑ´Ù. |
||
| ¿µ¹® | necrosis | ÇÑ±Û | ±«»ç |
|---|---|---|---|
| ¼³¸í | ¼¼Æ÷°¡ Á×´Â °ÍÀ» ¸»ÇÑ´Ù. ¿øÀÎÀº ¾î¶² ¿Ü»óÀÏ ¼öµµ ÀÖ°í, ȤÀº µ¿¸ÆÀÌ Á¼¾ÆÁ®¼ Çǰ¡ ÅëÇÏÁö ¾Ê¾Æ Á×°Ô µÇ´Â °ÍÀÏ ¼öµµ ÀÖ´Ù. ¾î¶² °æ¿ìÀ̵ç, ±«»çµÈ Á¶Á÷ÀÌ Ã¼³»¿¡ ÀÖÀ¸¸é, °á±¹Àº ¿©·¯ ÇÕº´ÁõÀ» ºÒ·¯ ÀÏÀ¸Å°¹Ç·Î Á¦°ÅµÇ¾î¾ß ÇÑ´Ù. ±«Àú±«»ç: gangrenous necrosis ±«Àú±«»ç¶ó´Â ¿ë¾î´Â º¸Åë ±«»ç¶ó´Â °Í°ú Å©°Ô ´Ù¸¥ °ÍÀº ¾øÀ¸³ª ÀÓ»ó, ƯÈ÷ ¿Ü°ú¿¡¼ ÈçÈ÷ ¾²°í ÀÖ´Â ¸»ÀÌ´Ù. ÀÌ´Â ÆÈ´Ù¸®, ƯÈ÷ ´Ù¸®¿¡¼ ¸¹ÀÌ »ý±â´Âµ¥ Ç÷¾×°ø±ÞÀÌ ¼Ò½ÇµÇ°í ±× ÈÄ¿¡ ¼¼±Õ°¨¿°À» ¹Þ¾Æ¼ »ý±â´Â º´ÅÍÀÌ´Ù. ¸¸¾à Ç÷·ù°ø±ÞÀÇ Â÷´Ü¿¡ ÀÇÇÑ Á¶Á÷ÀÇ Á×À½ÀÌ ÁÖº´º¯À̰í ÀÌÂ÷Àû ¼¼±ÕÀÇ °¨¿°ÀÌ Àû°í, ÀÖ´õ¶óµµ ¾ÆÁÖ ¹Ì¾àÇØ¼ º´ÅͰ¡ ¸¶¸£°í ¾×ü¼ººÐÀÌ ÀûÀ» °æ¿ì¿¡ À̰ÍÀ» °Ç¼º±«Àú(dry gangrene)À̶ó°í Çϰí, ¼¼±ÕÀÇ °¨¿°ÀÌ ¾ÆÁÖ ¸¹¾Æ¼ Á×Àº Á¶Á÷ÀÌ ºÐÇØ°¡ µÇ¾î¼ ¾×ü¼ººÐÀÌ ±«ÀúÀÇ Á¶Á÷¿¡ ¸¹ÀÌ ÀÖ¾î¼ º¸±â¿¡ ½ÀÇØ º¸À̸é À̰ÍÀ» ½À¼º±«Àú(wet gangrene)À̶ó°í ÇÑ´Ù. |
||
| ¿µ¹® | fibrinoid necrosis | ÇÑ±Û | ¼¶À¯¼Ò¼º±«»ç |
|---|---|---|---|
| ¼³¸í | ÃʱâÀÇ ·ù¸¶Æ¼½º ȤÀº ¾Ç¼ºÁ¾¾ç µî¿¡¼ º¼ ¼ö ÀÖ´Â Ç÷°ü-°áÇÕÁ¶Á÷ÀÇ Æ¯À¯ÇÑ º¯È·Î Ç÷°üº®À̳ª ÁÖÀ§ÀÇ °áÇÕÁ¶Á÷ÀÌ ¼¶À¯¼Ò¸ð¾çÀ¸·Î ±ÕÁúÇÑ ¹°Áú·Î µÇ°í, È£»ê¼ºÀ¸·Î ¿°»öµÈ´Ù. À̰ÍÀº ¼¶À¯¼Ò¿Í °ÅÀÇ ¶È°°Àº ¿°»ö¼ºÀ» ³ªÅ¸³»±â ¶§¹®¿¡ ¿°Áõ¿¡¼ Ç÷°üÀ¸·ÎºÎÅÍ ¼¶À¯¼Ò ¶Ç´Â ¼¶À¯¼Ò¸ð¾çÀÇ ¹°ÁúÀÌ »ïÃâÇÏ¿© °áÇÕÁ¶Á÷ ¼¶À¯°£¿¡ Ä§ÂøÇÏ¿© ±¸Á¶°¡ ºÒ¸í·áÇÑ °ÍÀ¸·Î »ý°¢µÇ¾úÀ¸³ª, ÃÖ±Ù Á¶Á÷ÈÇÐ, ÀüÀÚÇö¹Ì°æ µî¿¡ ÀÇÇÏ¿© °áÇÕ¼¶À¯ÀÚü¿¡µµ º¯È°¡ ÀÖ´Â °ÍÀ¸·Î ¸é¿ª±Û·ÎºÒ¸°ÀÇ Ä§Âøµµ Áõ¸íµÇ°í ÀÖ´Ù. |
||
| ¿µ¹® | coagulation necrosis | ÇÑ±Û | ÀÀ°í±«»ç |
|---|---|---|---|
| ¼³¸í | ¼¼Æ÷ÀÇ Á×À½À» ³ªÅ¸³»´Â ÇüÅÂÇÐÀû º¯È·Î¼ ±«»çºÎÀ§°¡ ÀÀ°íÇÑ »óÅ·ΠÀÖ´Â °Í. ±«»ç¼¼Æ÷´Â È£»ê¼º µ¢¾î¸®·Î º¸À̸ç Àû¾îµµ ¼öÀϰ£ ¼¼Æ÷ÀÇ ±âº» À±°ûÀÌ º¸Á¸µÇ±â ¶§¹®¿¡ Á¶Á÷±¸Á¶¸¦ ½Äº°ÇÒ ¼ö ÀÖ´Ù. ´ëÇ¥ÀûÀ¸·Î ÇãÇ÷±«»ç¸¦ µé ¼ö ÀÖ´Ù. °æ»ö°ú ÇãÇ÷¿¡ ÀÇÇÑ Àú»ê¼ÒÁõ½Ã ½ÉÀå±ÙÀ̳ª ÄáÆÏ¿¡¼ °üÂûµÇ°Å³ª Àü±â ¹× ¼öÀºÁßµ¶½Ã ÄáÆÏÀÇ ¿ä¼¼°ü¿¡¼ °üÂûµÇ´Â °ÍÀ¸·Î ´Ü¹éÀÇ º¯¼º ÈÄ ³²¾ÆÀֱ⠶§¹®ÀÌ´Ù. ¼¼Æ÷ÀÇ À±°ûÀÌ ³²¾Æ ÀÖ¾î ¿ø·¡ Á¶Á÷ÀÇ ±¸Á¶¸¦ ÇüÅÂÇÐÀûÀ¸·Î ÀνÄÇÒ ¼ö ÀÖ´Â °ÍÀÌ Æ¯Â¡ÀÌ´Ù. |
||
| BF | bentonite flocculation; bile flow; black female; blastogenic factor; blister fluid; blood flow; body... |
|---|---|
| ECD | ectrodactyly; electrochemical detector; electron capture detector; endocardial cushion defect; enzym... |
| enz | enzyme, enzymatic |
| AN | acanthosis nigricans; acne neonatorum; acoustic neuroma; adult, normal; ala nasi; amyl nitrate; aneu... |
| ARN | acute renal necrosis; acute retinal necrosis; arcuate nucleus; Association of Rehabilitation Nurses |
| NEG | Non-enzymatic glycosylation |
|---|---|
| % FAT | fat |
| AF | Abdominal fat |
| AVF | Abdominal visceral fat |
| BF | Body fat |
| subcutaneous fat necrosis of newborn | Indurated plaques and nodules appearing usually a few days or a few weeks after birth and usually resolving within a few months, characterised microscopically by birefringent needle-shaped crystals within necrotic fat cells; the condition remains localised, unlike sclerema neonatorum. (05 Mar 2000) |
|---|---|
| fat necrosis | A condition in which the neutral fats in the cells of adipose tissue are split into fatty acids and glycerol. (12 Dec 1998) |
| fat necrosis tumour | <surgery> Destruction of fat cells in the breast due to trauma or injury that can cause a hard noncancerous lump. (09 Oct 1997) |
| enzymatic | Relating to an enzyme. Synonym: enzymic. (05 Mar 2000) |
| enzymatic hydrolysis | A process by which enzymes (biological catalysts) are used to break down starch or cellulose into sugar. (05 Dec 1998) |
| enzymatic synthesis | Synthesis by enzymes. See: biosynthesis. (05 Mar 2000) |
| acute tubular necrosis | <nephrology> A kidney disorder that results in damage to the renal tubule cells leading to acute renal failure. Acute tubular necrosis can result from any condition which deprives the kidney of oxygen (ischaemia). Acute tubular necrosis may occur as a complication of shock, trauma or sepsis. Conditions such as diabetes or liver disease can predispose people to the development of acute tubular necrosis. Certain medications (for example aminoglycosides, amphotericin B, cyclosporine) are known to cause acute tubular necrosis as a toxic side effect. Radiopaque contrast dyes, used in some radiologic procedures, may also result in acute tubular necrosis as a rare complication from contrast dye use. Acronym: ATN (13 Nov 1997) |
| aseptic necrosis | <orthopaedics, pathology> Condition in which poor blood supply to an area of bone leads to bone death. Also called avascular necrosis and osteonecrosis. (12 Dec 1998) |
| avascular necrosis | <radiology> Aetiology (PLASTIC RAGS): P pancreatitis, L lupus, A alcohol, S steroids, T trauma, I idiopathic, infection, C caisson disease, collagen vascular disease, R radiation, rheumatoid arthritis, A amyloid, G Gaucher disease, S sickle cell disease findings: sclerosis, crescent sign, collapse (e.g., of femoral head) see also: staging (12 Dec 1998) |
| avascular necrosis staging | <radiology> Stage CT/X-ray bone scan I - cold/hot spot II sclerotic focus with osteopenic ring III crescent sign (subchondral lucency) IV articular collapse flattening of femoral head sensitivity 86% 78% specificity 79% 75% see also: avascular necrosis (AVN) (12 Dec 1998) |
| bridging hepatic necrosis | Area of liver necrosis which bridges adjacent portal areas and central veins; subsequent post-necrotic collapse and fibrosis is likely to result in cirrhosis. (05 Mar 2000) |
| p60 tumour necrosis factor receptor-associated kinase | <enzyme> Interacts with and causes phosphorylation of the cytoplasmic domain of the tnf receptor Registry number: EC 2.7.10.- Synonym: p60 tnf receptor-associated kinase, p60-trak (26 Jun 1999) |
| papillary necrosis | <radiology> Mnemonic: POST CARD, P pyelonephritis, O obstruction, S sickle cell disease, T TB, C cirrhosis (EtOH), A analgesics (phenacetin and aspirin), R renal vein thrombosis, D diabetes (12 Dec 1998) |
| receptors, tumour necrosis factor | Cell surface receptors that bind tumour necrosis factor and trigger changes which influence the behaviour of cells. The two recognised tumour necrosis factor receptors are designated alpha and beta receptors. Both receptors bind both alpha and beta tumour necrosis factors with high affinity, and both are members of the nerve growth factor receptor family. (12 Dec 1998) |
| caseous necrosis | Caseation necrosis, necrosis characteristic of certain inflammations (e.g., tuberculosis, histoplasmosis), which represents necrosis with loss of separate structures of the various cellular and histologic elements; affected tissue manifests the friable, crumbly consistency and dull, opaque quality observed in cheese. Synonym: caseous degeneration. (05 Mar 2000) |
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|